CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-01 | Powell Andrew Kenneth William Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2023-06-01 | Powell Andrew Kenneth William Director | Grant or award · Restricted Stock Units | +4,660 | 4,660 | ||
| 2023-06-01 | Mehra Anand Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2023-06-01 | Mehra Anand Director | Grant or award · Restricted Stock Units | +4,660 | 4,660 | ||
| 2023-03-17 | Manion Douglas J. Pres and CEO | Purchase | +6,300 | $7.86 | $50K | 12,800 |
| 2023-03-09 | Manion Douglas J. Pres and CEO | Purchase | +6,500 | $7.74 | $50K | 6,500 |
| 2023-03-03 | Walker Neal Director | Sale | −30,240 | $12.63 | $382K | 1,273,202 |
| 2023-03-03 | Monahan Joseph Chief Scientific Officer | Sale | −16,037 | $12.63 | $203K | 147,724 |
| 2023-03-03 | Balthaser Kevin Chief Financial Officer | Sale | −894 | $12.63 | $11K | 5,256 |
| 2023-03-02 | Walker Neal Director | Sale | −29,000 | $12.37 | $359K | 1,285,188 |
| 2023-03-02 | Walker Neal Director | Option exercise | +18,254 | 1,303,442 | ||
| 2023-03-02 | Walker Neal Director | Option exercise · Restricted Stock Units | −18,254 | 18,254 | ||
| 2023-03-02 | Monahan Joseph Chief Scientific Officer | Sale | −14,800 | $12.37 | $183K | 151,261 |
| 2023-03-02 | Monahan Joseph Chief Scientific Officer | Option exercise | +12,500 | 163,761 | ||
| 2023-03-02 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −12,500 | 12,500 | ||
| 2023-03-02 | Balthaser Kevin Chief Financial Officer | Sale | −1,000 | $12.29 | $12K | 4,650 |
| 2023-03-02 | Balthaser Kevin Chief Financial Officer | Option exercise | +1,500 | 6,150 | ||
| 2023-03-02 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −1,500 | 1,500 | ||
| 2023-03-01 | Walker Neal Director | Option exercise | +96,150 | 1,271,913 | ||
| 2023-03-01 | Walker Neal Director | Option exercise | +18,275 | 1,290,188 |
Page 20 of 34 · 680 trades